On 2025-03-28, ImmunoPrecise Antibodies Ltd. (IPA) announced earnings per share of $-0.06 for the fiscal quarter ending 2025-01-31, meeting the average analyst estimate of $-0.06.
The next expected annoucement date for quarterly earnings is 2025-08-04, with an average estimated earnings per share of $-0.02 for the fiscal quarter ending 2025-04-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-03-28 | 2025-01-31 | $-0.06 | $-0.06 |
| 2024-12-10 | 2024-10-31 | $-0.05 | $-0.07 |
| 2024-09-16 | 2024-07-31 | $-0.09 | $-0.11 |
| 2024-07-29 | 2024-04-30 | $-0.10 | $-0.52 |
| 2024-03-14 | 2024-01-31 | $-0.08 | $-0.08 |
| 2023-12-14 | 2023-10-31 | $-0.09 | $-0.07 |
| 2023-09-14 | 2023-07-31 | $-0.17 | $-0.11 |
| 2023-07-10 | 2023-04-30 | $-0.12 | $-0.15 |
| 2023-03-16 | 2023-01-31 | $-0.12 | $-0.14 |
| 2022-12-15 | 2022-10-31 | $-0.14 | $-0.23 |
| 2022-09-14 | 2022-07-31 | -- | $-0.30 |
| 2022-07-29 | 2022-04-30 | -- | $-0.17 |
| 2022-03-16 | 2022-01-31 | -- | $-0.16 |
| 2021-12-13 | 2021-10-31 | -- | $-0.21 |
| 2021-09-09 | 2021-07-31 | -- | $-0.14 |
| 2021-07-28 | 2021-04-30 | -- | $-0.23 |